Y. Cui

发表

A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol

Ying Cheng, E. Li, Yanqiao Zhang, 2023, Technology in cancer research & treatment.